WEDNESDAY, April 24, 2024 (HealthDay News) -- A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the...
The following is a summary of "Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to...
WEDNESDAY, April 24, 2024 (HealthDay News) -- A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss...
WEDNESDAY, April 24, 2024 (HealthDay News) -- A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Wearable technology is feasible to assess postural ergonomics and...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Middle-aged Black women with better heart health are less likely to show...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Self-administered acupressure (SAA) is an efficacious and cost-effective...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Northeastern U.S. seafood consumers may be exposed to per- and...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Computed tomography fractional flow reserve (CT-FFR) improves assessment...
WEDNESDAY, April 24, 2024 (HealthDay News) -- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to...
